News Arquivos - Instituto Gulbenkian de Ciência

Marco Fumasoni

Open item in modal

Find out more

1" x-on:mousedown="getPositions($event)" x-on:mouseup="disable()" x-on:mouseleave="disable()" x-on:mousemove="zoomPan($event)" x-on:touchstart="getPositions($event)" x-on:touchend="disable()" x-on:touchcancel="disable()" x-on:touchmove="zoomPan($event)" >

Zoom out <path d="M288 192H128C119.2 192 112 199.2 112 208S119.2 224 128 224h160c8.844 0 16-7.156 16-16S296.8 192 288 192zM507.3 484.7l-141.5-141.5C397 306.8 416 259.7 416 208C416 93.13 322.9 0 208 0S0 93.13 0 208S93.13 416 208 416c51.68 0 98.85-18.96 135.2-50.15l141.5 141.5C487.8 510.4 491.9 512 496 512s8.188-1.562 11.31-4.688C513.6 501.1 513.6 490.9 507.3 484.7zM208 384C110.1 384 32 305 32 208S110.1 32 208 32S384 110.1 384 208S305 384 208 384z"/> Zoom in <path d="M288 192H224V128c0-8.844-7.156-16-16-16S192 119.2 192 128v64H128C119.2 192 112 199.2 112 208S119.2 224 128 224h64v64c0 8.844 7.156 16 16 16S224 296.8 224 288V224h64c8.844 0 16-7.156 16-16S296.8 192 288 192zM507.3 484.7l-141.5-141.5C397 306.8 416 259.7 416 208C416 93.13 322.9 0 208 0S0 93.13 0 208S93.13 416 208 416c51.68 0 98.85-18.96 135.2-50.15l141.5 141.5C487.8 510.4 491.9 512 496 512s8.188-1.562 11.31-4.688C513.6 501.1 513.6 490.9 507.3 484.7zM208 384C110.1 384 32 305 32 208S110.1 32 208 32S384 110.1 384 208S305 384 208 384z"/> Close

1" x-bind:disabled="current

1" x-bind:disabled="current + 1 >= slides.length" x-on:click="next()" >

This competitive initiative “provides a tremendous opportunity for researchers to embark on a wide-range of ambitious life science projects,” says EMBO Director Fiona Watt. “The programme supports group leaders in founding and growing their labs, provides mentoring, networking and training opportunities, and also helps build vibrant, interdisciplinary national and international research communities.” The new EMBO Installation Grantees will establish laboratories in seven countries and receive 50 000 euros annually for three to five years. They can also apply for additional grants of up to 10 000 euros per year.

Evolutionary Rewiring Genome Maintenance Marco Fumasoni, Instituto Gulbenkian de Ciência (IGC)

Originally from Italy, Marco Fumasoni arrived at the IGC in 2021 to start his lab Genome Maintenance and Evolution . With this EMBO Installation Grant, the researcher will develop the research project “Evolutionary Rewiring Genome Maintenance (EVOREWIRE)” which will deepen our understanding of the evolution of nuclear cell biology in nature, as well as during cancer and premature ageing, which are caused by mutations that perturb the faithful transmission of genetic material. The faithful maintenance of genomes is essential for life and depends on the precise execution of DNA replication, repair, and segregation of chromosomes at every cell division. While the function and overall logic of these processes are widely conserved, they show a surprising mechanistic variability in how they are executed in different species. But “the functional significance of these differences and the evolutionary processes that can generate them are still largely unknown”, Marco explains. To answer these questions, in this EMBO project, the researcher developed an integrative approach based on the unicellular microorganism S. cerevisiae , which combines genomics, evolutionary, cellular, and molecular biology.

This EMBO Installation grant “is a fantastic opportunity to establish my laboratory in Portugal with the best resources and to integrate my research within the European network of excellence represented by the EMBO community”, Marco highlights. The researcher was initially trained as a molecular geneticist studying the mechanisms that maintain genome stability in the labs of Marco Foiani and Dana Branzei at the University of Milan and Istituto Fondazione di Oncologia Molecolare (IFOM), where he received his Ph.D. Before joining the IGC, he moved to Harvard University (USA) where he used experimental evolution combined with molecular, cellular, and quantitative approaches to study the mechanisms and dynamics of genome evolution, mentored by Andrew Murray.

<img aria-describedby="caption-attachment-33343" decoding="async" loading="lazy" class="wp-image-33343 size-full" src="https://gulbenkian.pt/ciencia/wp-content/uploads/sites/47/2023/01/Ana-Luisa-peq.jpg" alt="" width="600" height="456" srcset="https://gulbenkian.pt/ciencia/wp-content/uploads/sites/47/2023/01/Ana-Luisa-peq.jpg 600w, https://gulbenkian.pt/ciencia/wp-content/uploads/sites/47/2023/01/Ana-Luisa-peq-300x228.jpg 300w, https://gulbenkian.pt/ciencia/wp-content/uploads/sites/47/2023/01/Ana-Luisa-peq-288x219.jpg 288w, https://gulbenkian.pt/ciencia/wp-content/uploads/sites/47/2023/01/Ana-Luisa-peq-576x438.jpg 576w" sizes="(max-width: 600px) 100vw, 600px" /> Ana Luísa Correia © Alexandre Azinheira, Fundação Champalimaud

Cracking the challenge of dormancy in metastatic cancer Ana Luísa Correia, Champalimaud Foundation

After over 12 years abroad, Ana Luísa returned to Portugal to become a Principal Investigator at the Champalimaud Foundation, where she leads the Cancer Dormancy & Immunity Lab .“Receiving this EMBO Installation Grant is a unique opportunity for our recently created group at the Champalimaud Foundation to belong to the distinguished EMBO community and pursue our long term research goal – to understand what brings disseminated tumour cells in and out of dormancy, and how these dormant cells can be targeted”, says Ana Luísa.

Metastases arising in distant sites continue to cause the vast majority of all cancer-related deaths. In many patients with cancer, metastases emerge long after successful treatment of the primary tumour. This is because persistent disseminated tumour cells (or DTCs) find residency at distant sites under a state of dormancy, only to awaken years or even decades afterwards and initiate deadly metastases. The group is studying this challenge in the context of breast cancer, which most often spreads to the bones, liver, lung, brain and lymph nodes: “Because immune cells in tissues are first responders to DTCs arriving at distant sites, we are particularly interested in understanding how tissue-specific immunity contributes to the differential emergence of metastases, and whether normalising tissue immune physiology might be a way to effectively control dormant DTCs”, Ana Luísa explains.

About EMBO

EMBO is an international organisation of life scientists which allocates direct funding from member states towards research fellowships, courses, workshops, conferences, and science policy initiatives. EMBO Installation Grants support group leaders establishing laboratories in countries participating in the scheme to strengthen the life sciences there. Installation grantees become part of an international network of more than 600 current and former EMBO Young Investigators, Installation Grantees and Global Investigators, benefiting from extensive networking opportunities, training, and practical support, as well as access to core facilities at the European Molecular Biology Laboratory (EMBL).